UK Promises RWD Guidance In Plan To Boost Trial Innovation
The UK medicines regulator has published a new plan to deliver on several short-term projects as it tries to keep pace with the fast-moving life sciences sector and the needs of patients.
You may also be interested in...
The UK government has revealed a number of changes it is making to the health care system in response to a report that found serious lapses regarding the safety of patients who were using certain treatments.
The three-year Delivery Plan just unveiled by the UK medicines agency is part of its aim to create a “new era” in drug regulation.
The UK government has set aside over £64m ($89m) to support the first phase of activities to be undertaken in the coming months under a two-part initiative to strengthen clinical research delivery.